Biotech firm aims to create ‘ChatGPT of biology’ – will it work? #Science #TechnologyandEngineering #BiotechInnovation #ArtificialIntelligence #ChatGPT
Biotech firm aims to create ‘ChatGPT of biology’ – will it work?
A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and billions of newly identified genes – but even this trove of data may not be...
purescience.news
June 18, 2025 at 3:01 AM
Biotech firm aims to create ‘ChatGPT of biology’ – will it work? #Science #TechnologyandEngineering #BiotechInnovation #ArtificialIntelligence #ChatGPT
Achieve Life Sciences’ #CEO Rick Stewart shares a success with its development of cytisinicline.
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences
September 25, 2025 at 2:15 PM
Achieve Life Sciences’ #CEO Rick Stewart shares a success with its development of cytisinicline.
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences
Chief Commercial Officer Jaime Xinos explains Achieve Life Sciences’ strategy to deploy digital resources for maximum effect.
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences #PublicHealth #AddictionResearch #TobaccoFreeFuture #HealthEquity #MedicalResearch #Biopharma
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences #PublicHealth #AddictionResearch #TobaccoFreeFuture #HealthEquity #MedicalResearch #Biopharma
October 13, 2025 at 12:49 PM
Chief Commercial Officer Jaime Xinos explains Achieve Life Sciences’ strategy to deploy digital resources for maximum effect.
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences #PublicHealth #AddictionResearch #TobaccoFreeFuture #HealthEquity #MedicalResearch #Biopharma
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences #PublicHealth #AddictionResearch #TobaccoFreeFuture #HealthEquity #MedicalResearch #Biopharma
🧫 Synthetic Biology Market to hit $186.48B by 2034 at 25.90% CAGR! Engineering biology for the future. #SynBio #BiotechInnovation 👉 www.einpresswire.com/article/7886...
Synthetic Biology Market Expected to Hit USD 186.48 Billion by 2034 with a Remarkable 25.90% CAGR
The Synthetic Biology Market Industry is witnessing rapid advancements in technology, which act as a significant driver for market growth.
www.einpresswire.com
October 30, 2025 at 12:03 PM
🧫 Synthetic Biology Market to hit $186.48B by 2034 at 25.90% CAGR! Engineering biology for the future. #SynBio #BiotechInnovation 👉 www.einpresswire.com/article/7886...
🩸 Turning any blood type into universal type O
What if we didn’t have to match blood types anymore?
Avivo Bio is on it!
🧬 Learn more:
genomebc.ca/projects/tim...
#BloodDonation #BiotechInnovation #HealthTech #GenomicsInBC #GIF2025
What if we didn’t have to match blood types anymore?
Avivo Bio is on it!
🧬 Learn more:
genomebc.ca/projects/tim...
#BloodDonation #BiotechInnovation #HealthTech #GenomicsInBC #GIF2025
August 15, 2025 at 4:05 PM
🩸 Turning any blood type into universal type O
What if we didn’t have to match blood types anymore?
Avivo Bio is on it!
🧬 Learn more:
genomebc.ca/projects/tim...
#BloodDonation #BiotechInnovation #HealthTech #GenomicsInBC #GIF2025
What if we didn’t have to match blood types anymore?
Avivo Bio is on it!
🧬 Learn more:
genomebc.ca/projects/tim...
#BloodDonation #BiotechInnovation #HealthTech #GenomicsInBC #GIF2025
ten23 health and Neumirna Therapeutics have joined forces to advance NMT.001, an RNA-based therapy aimed at treating drug-resistant epilepsy.
#News #RNAtherapy #EpilepsyResearch #BiotechInnovation #ten23health #NeumirnaTherapeutics #Neurology #OligonucleotideTherapy #LifeSciences
#News #RNAtherapy #EpilepsyResearch #BiotechInnovation #ten23health #NeumirnaTherapeutics #Neurology #OligonucleotideTherapy #LifeSciences
ten23 health and Neumirna partner to advance RNA therapy for epilepsy
The collaboration seeks to advance NMT.001, an RNA-based therapy targeting microRNAs involved in drug-resistant epilepsy.
druganddeviceworld.com
October 28, 2025 at 4:24 PM
ten23 health and Neumirna Therapeutics have joined forces to advance NMT.001, an RNA-based therapy aimed at treating drug-resistant epilepsy.
#News #RNAtherapy #EpilepsyResearch #BiotechInnovation #ten23health #NeumirnaTherapeutics #Neurology #OligonucleotideTherapy #LifeSciences
#News #RNAtherapy #EpilepsyResearch #BiotechInnovation #ten23health #NeumirnaTherapeutics #Neurology #OligonucleotideTherapy #LifeSciences
🧬 Protein Revolution: The Tiny Model Making a Massive Impact!
PoET-2 is changing the game in computational protein design, slashing experimental data needs by 30x! 🚀
learn more: www.synbiobeta.com/read/protein...
#ProteinDesign #BiotechInnovation #AIRevolution
PoET-2 is changing the game in computational protein design, slashing experimental data needs by 30x! 🚀
learn more: www.synbiobeta.com/read/protein...
#ProteinDesign #BiotechInnovation #AIRevolution
Protein Revolution: The Tiny Model Making a Massive Impact - SynBioBeta
www.synbiobeta.com
February 21, 2025 at 12:19 AM
🧬 Protein Revolution: The Tiny Model Making a Massive Impact!
PoET-2 is changing the game in computational protein design, slashing experimental data needs by 30x! 🚀
learn more: www.synbiobeta.com/read/protein...
#ProteinDesign #BiotechInnovation #AIRevolution
PoET-2 is changing the game in computational protein design, slashing experimental data needs by 30x! 🚀
learn more: www.synbiobeta.com/read/protein...
#ProteinDesign #BiotechInnovation #AIRevolution
Scientists filmed DNA unzipping in real-time! This breakthrough could revolutionize cancer and virus treatment. #DNAReplication #CancerResearch #BiotechInnovation
DNA Unzipped: New Microscopy Breakthrough Paves Way for Cancer and Virus Therapies
Scientists at Leicester have filmed DNA unzipping in real-time. This molecular movie could lead to new treatments for cancer and viral infections.
geekoo.news
March 22, 2025 at 12:00 AM
Scientists filmed DNA unzipping in real-time! This breakthrough could revolutionize cancer and virus treatment. #DNAReplication #CancerResearch #BiotechInnovation
Cross-licensing agreement brings reformulated rimiducid to cell and gene therapies, with implications for oncology and longevity medicine.
longevity.technology/news/phoenix...
#longevity #celltherapy #genetherapy #safetyswitch #rimiducid #biotechinnovation #MDAnderson #PhoenixSENOLYTIX
longevity.technology/news/phoenix...
#longevity #celltherapy #genetherapy #safetyswitch #rimiducid #biotechinnovation #MDAnderson #PhoenixSENOLYTIX
September 15, 2025 at 3:27 PM
Cross-licensing agreement brings reformulated rimiducid to cell and gene therapies, with implications for oncology and longevity medicine.
longevity.technology/news/phoenix...
#longevity #celltherapy #genetherapy #safetyswitch #rimiducid #biotechinnovation #MDAnderson #PhoenixSENOLYTIX
longevity.technology/news/phoenix...
#longevity #celltherapy #genetherapy #safetyswitch #rimiducid #biotechinnovation #MDAnderson #PhoenixSENOLYTIX
Oklahoma City is on the brink of a biotech boom, with ARL Ballet Farmer's expansion promising 433 new jobs and a significant boost to the local economy!
Click to read more!
#OK #CitizenPortal #JobCreation #EconomicGrowth #BiotechInnovation
Click to read more!
#OK #CitizenPortal #JobCreation #EconomicGrowth #BiotechInnovation
ARL Ballet Farmer Plans Expansion in Oklahoma City Creating 433 New Jobs
ARL Ballet Farmer aims to create 433 jobs while expanding laboratory services in Oklahoma City.
citizenportal.ai
September 29, 2025 at 5:34 AM
Oklahoma City is on the brink of a biotech boom, with ARL Ballet Farmer's expansion promising 433 new jobs and a significant boost to the local economy!
Click to read more!
#OK #CitizenPortal #JobCreation #EconomicGrowth #BiotechInnovation
Click to read more!
#OK #CitizenPortal #JobCreation #EconomicGrowth #BiotechInnovation
Dr. Rohit Kadam bridges biotech and equity by making diagnostics more accessible—transforming global health through impact, not accolades. #biotechinnovation
Engineering Health Equity: How Rohit Kadam Is Using Biotech to Close the Gaps in Global Diagnostics
hackernoon.com
June 9, 2025 at 7:29 PM
Dr. Rohit Kadam bridges biotech and equity by making diagnostics more accessible—transforming global health through impact, not accolades. #biotechinnovation
The Final Synthetic Yeast Genome is Now a Reality 🧬
The global Sc2.0 project reaches its conclusion, setting the stage for sustainable biotech innovation
read more: www.synbiobeta.com/read/the-fin...
#BiotechInnovation #Sustainability #Genomics #FutureOfScience
The global Sc2.0 project reaches its conclusion, setting the stage for sustainable biotech innovation
read more: www.synbiobeta.com/read/the-fin...
#BiotechInnovation #Sustainability #Genomics #FutureOfScience
The Final Synthetic Yeast Genome is Now a Reality—And What That Means for Biotech - SynBioBeta
www.synbiobeta.com
February 6, 2025 at 1:04 AM
The Final Synthetic Yeast Genome is Now a Reality 🧬
The global Sc2.0 project reaches its conclusion, setting the stage for sustainable biotech innovation
read more: www.synbiobeta.com/read/the-fin...
#BiotechInnovation #Sustainability #Genomics #FutureOfScience
The global Sc2.0 project reaches its conclusion, setting the stage for sustainable biotech innovation
read more: www.synbiobeta.com/read/the-fin...
#BiotechInnovation #Sustainability #Genomics #FutureOfScience
Some-bunny once told us that innovation never stops—and neither do we! 🐰
This Easter weekend, we're celebrating the perfect blend of persistence and playfulness that drives biotech forward, and feeling eggs-tremely thankful for our incredible community!
#BiotechInnovation #Healthcare #Easter
This Easter weekend, we're celebrating the perfect blend of persistence and playfulness that drives biotech forward, and feeling eggs-tremely thankful for our incredible community!
#BiotechInnovation #Healthcare #Easter
April 18, 2025 at 3:41 PM
Some-bunny once told us that innovation never stops—and neither do we! 🐰
This Easter weekend, we're celebrating the perfect blend of persistence and playfulness that drives biotech forward, and feeling eggs-tremely thankful for our incredible community!
#BiotechInnovation #Healthcare #Easter
This Easter weekend, we're celebrating the perfect blend of persistence and playfulness that drives biotech forward, and feeling eggs-tremely thankful for our incredible community!
#BiotechInnovation #Healthcare #Easter
#HIVCure #GeneEditing #CRISPR #CRISPRCas9 #GeneTherapy #MedicalBreakthrough #BiotechInnovation #HIVTreatment #VirusRemoval #FutureOfMedicine #ExcisionBioTherapeutics #EBT101 #AmsterdamUMC #HIVResearch #ImmuneCells #ScienceNews #MolecularScissors #BreakthroughScience #FuturisticMedicine #MedicalInnov
July 31, 2025 at 7:00 PM
#HIVCure #GeneEditing #CRISPR #CRISPRCas9 #GeneTherapy #MedicalBreakthrough #BiotechInnovation #HIVTreatment #VirusRemoval #FutureOfMedicine #ExcisionBioTherapeutics #EBT101 #AmsterdamUMC #HIVResearch #ImmuneCells #ScienceNews #MolecularScissors #BreakthroughScience #FuturisticMedicine #MedicalInnov
LucidQuest Views >>> Cell and Gene Therapy Weekly News – July 24th 2025 #News #BiotechInnovation #CAR_T #cellandgenetherapy Comment below!
Cell and Gene Therapy Weekly News – July 24th 2025
🧬 This Week in Gene & Cell Therapy: Klotho’s Gene Therapy Deal, Sarepta’s FDA Challenge, NKGen Approval and More From […]
The post Cell and Gene Therapy Weekly News – July 24th 2025 appeared first on LucidQuest Ventures.
dlvr.it
July 24, 2025 at 10:50 AM
LucidQuest Views >>> Cell and Gene Therapy Weekly News – July 24th 2025 #News #BiotechInnovation #CAR_T #cellandgenetherapy Comment below!
Gene traffic control?
That’s not sci-fi, that’s what Foghorn Therapeutics is presenting.
In the pharma world we lead, awareness of platforms becomes competitive advantage.
The future is the platforms behind the drugs not just drugs.
#BiotechInnovation #GeneTherapy #PharmaLeadership #WomenInScience
That’s not sci-fi, that’s what Foghorn Therapeutics is presenting.
In the pharma world we lead, awareness of platforms becomes competitive advantage.
The future is the platforms behind the drugs not just drugs.
#BiotechInnovation #GeneTherapy #PharmaLeadership #WomenInScience
Foghorn Therapeutics Inc. to Participate in Major Healthcare Conferences in November 2025 | FHTX Stock News
Foghorn Therapeutics will present at three upcoming healthcare conferences, focusing on its innovati
quiverquant.com
November 6, 2025 at 5:08 AM
Gene traffic control?
That’s not sci-fi, that’s what Foghorn Therapeutics is presenting.
In the pharma world we lead, awareness of platforms becomes competitive advantage.
The future is the platforms behind the drugs not just drugs.
#BiotechInnovation #GeneTherapy #PharmaLeadership #WomenInScience
That’s not sci-fi, that’s what Foghorn Therapeutics is presenting.
In the pharma world we lead, awareness of platforms becomes competitive advantage.
The future is the platforms behind the drugs not just drugs.
#BiotechInnovation #GeneTherapy #PharmaLeadership #WomenInScience
Dr. Daniel Chen and Oxperial BioHealth have unveiled GPDT, a sunlight-activated technology using plant compounds to boost your body’s natural defenses and target cancer cells—especially brain cancer. #CancerPrevention #SunlightTherapy #PhotodynamicTherapy
#GreenTech #BiotechInnovation #GPDT
#GreenTech #BiotechInnovation #GPDT
April 17, 2025 at 8:20 AM
Dr. Daniel Chen and Oxperial BioHealth have unveiled GPDT, a sunlight-activated technology using plant compounds to boost your body’s natural defenses and target cancer cells—especially brain cancer. #CancerPrevention #SunlightTherapy #PhotodynamicTherapy
#GreenTech #BiotechInnovation #GPDT
#GreenTech #BiotechInnovation #GPDT
Transform phase-separated protein condensates with interfacial cages! One-pot assembly method brings precise control and new biomaterial possibilities. #BiotechInnovation PMID:39856105, Nat Commun 2025, @NatureComms https://doi.org/10.1038/s41467-025-56391-y
February 18, 2025 at 2:10 PM
Transform phase-separated protein condensates with interfacial cages! One-pot assembly method brings precise control and new biomaterial possibilities. #BiotechInnovation PMID:39856105, Nat Commun 2025, @NatureComms https://doi.org/10.1038/s41467-025-56391-y
What Does Dyadic’s Name Change Mean?
Join Unboxing Biotech and Dyadic Applied BioSolutions COO Joe Hazelton for a discussion.
$DYAI
#Biotechnology #LifeSciences #BiotechInnovation #SyntheticBiology #ProteinEngineering
Join Unboxing Biotech and Dyadic Applied BioSolutions COO Joe Hazelton for a discussion.
$DYAI
#Biotechnology #LifeSciences #BiotechInnovation #SyntheticBiology #ProteinEngineering
August 22, 2025 at 3:34 PM
What Does Dyadic’s Name Change Mean?
Join Unboxing Biotech and Dyadic Applied BioSolutions COO Joe Hazelton for a discussion.
$DYAI
#Biotechnology #LifeSciences #BiotechInnovation #SyntheticBiology #ProteinEngineering
Join Unboxing Biotech and Dyadic Applied BioSolutions COO Joe Hazelton for a discussion.
$DYAI
#Biotechnology #LifeSciences #BiotechInnovation #SyntheticBiology #ProteinEngineering
Eli Lilly offers free access to its AI models for small biotech firms! How will this impact drug development? #BiotechInnovation
https://www.statnews.com/2025/09/09/eli-lilly-ai-tunelab-biotech-drug-insitro/
https://www.statnews.com/2025/09/09/eli-lilly-ai-tunelab-biotech-drug-insitro/
Lilly will let small biotechs use its AI models at no cost
Lilly is opening up its proprietary AI models to biotech companies that want to use them to jumpstart their science.
www.statnews.com
September 9, 2025 at 8:52 PM
Eli Lilly offers free access to its AI models for small biotech firms! How will this impact drug development? #BiotechInnovation
https://www.statnews.com/2025/09/09/eli-lilly-ai-tunelab-biotech-drug-insitro/
https://www.statnews.com/2025/09/09/eli-lilly-ai-tunelab-biotech-drug-insitro/
🚀 What’s New at SynBioBeta 2025?
Get ready for an even bigger and better event!
#SynBioBeta2025 #SyntheticBiology #biotechinnovation
Get ready for an even bigger and better event!
#SynBioBeta2025 #SyntheticBiology #biotechinnovation
February 12, 2025 at 6:29 PM
🚀 What’s New at SynBioBeta 2025?
Get ready for an even bigger and better event!
#SynBioBeta2025 #SyntheticBiology #biotechinnovation
Get ready for an even bigger and better event!
#SynBioBeta2025 #SyntheticBiology #biotechinnovation
🚀 Cellino & Mass General Brigham launch the U.S.'s first Nebula-powered iPSC Foundry!
Using AI-driven tech, they aim to decentralize biomanufacturing & scale patient-specific cell therapies.
First stop: a Parkinson’s therapy. 🌱🧠
#RegenerativeMedicine #BiotechInnovation
Using AI-driven tech, they aim to decentralize biomanufacturing & scale patient-specific cell therapies.
First stop: a Parkinson’s therapy. 🌱🧠
#RegenerativeMedicine #BiotechInnovation
Cellino Launches U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing
Cellino Launches U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing
https://www.businesswire.com/news/home/20250224202433/en/Cellino-Launches-U.S.’s-First-Nebula-Powered-iPSC-Foundry-for-Scalable-Autologous-Biomanufacturing
March 3, 2025 at 2:56 PM
🚀 Cellino & Mass General Brigham launch the U.S.'s first Nebula-powered iPSC Foundry!
Using AI-driven tech, they aim to decentralize biomanufacturing & scale patient-specific cell therapies.
First stop: a Parkinson’s therapy. 🌱🧠
#RegenerativeMedicine #BiotechInnovation
Using AI-driven tech, they aim to decentralize biomanufacturing & scale patient-specific cell therapies.
First stop: a Parkinson’s therapy. 🌱🧠
#RegenerativeMedicine #BiotechInnovation
📢 See you tomorrow at the BIA Start-up Festival!
VectorBuilder is excited to join the UK biotech community at Glaziers Hall, London — May 22, 9am–7pm BST.
A full day of innovation, networking & inspiration!
#BIAStartupFestival #BiotechInnovation #LifeSciences
VectorBuilder is excited to join the UK biotech community at Glaziers Hall, London — May 22, 9am–7pm BST.
A full day of innovation, networking & inspiration!
#BIAStartupFestival #BiotechInnovation #LifeSciences
May 21, 2025 at 8:04 PM
📢 See you tomorrow at the BIA Start-up Festival!
VectorBuilder is excited to join the UK biotech community at Glaziers Hall, London — May 22, 9am–7pm BST.
A full day of innovation, networking & inspiration!
#BIAStartupFestival #BiotechInnovation #LifeSciences
VectorBuilder is excited to join the UK biotech community at Glaziers Hall, London — May 22, 9am–7pm BST.
A full day of innovation, networking & inspiration!
#BIAStartupFestival #BiotechInnovation #LifeSciences